Pharmacological interventions to decompression sickness in rats: Comparison of five agents

Aviation Space and Environmental Medicine

Volumn 79, Issue 1, 2008, Pages 7-13

  Montcalm Smith, Elizabeth A ^a   Fahlman, Andreas ^b   Kayar, Susan R ^a   Temple, Diana J ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adjunctive therapy; Alpha phenyl N butylnitorne; Aspirin; DCS; Lidocaine; Methylprednisolone; Transsodium crocetinate

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; CROCETIN; LIDOCAINE; METHYLPREDNISOLONE; N TERT BUTYL ALPHA PHENYLNITRONE; TRANSSODIUM CROCETINATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREATHING; CONTROLLED STUDY; DEATH; DECOMPRESSION SICKNESS; DIVING; DRUG EFFECT; INCIDENCE; MALE; NONHUMAN; RAT; SYMPTOM; TREATMENT OUTCOME;

AIR PRESSURE; ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTICOAGULANTS; ASPIRIN; CYCLIC N-OXIDES; DECOMPRESSION SICKNESS; KAPLAN-MEIERS ESTIMATE; LIDOCAINE; METHYLPREDNISOLONE; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME; VITAMIN A;

ANIMALIA; RATTUS;

EID: 37749018623     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: 10.3357/ASEM.2071.2008     Document Type: Article

References (48)

1. Bennett M, Mitchell S, Dominguez A. Adjunctive treatment of decompression illness with a non-steroidal anti-inflammatory drug (Tenoxicam) reduces compression requirement. Undersea Hyperb Med 2003; 30:195-205.
2. Bennett PB. A review of protective pharmacological agents in diving. Aerosp Med 1972; 43:184-92.
3. Bennett PB, Brock AJ. Action of selected drugs on decompression sickness in rats. Aerosp Med 1969; 40:607-10.
4. Bigger J, Hoffman B. Antiarrhythmic drugs. In: Goodman-Gilman A, Rall T, Nies A, Taylor P, eds. The pharmacological basis of therapeutics. New York: McGraw-Hill; 1990:840-73.
5. Bove AA. The basis for drug therapy in decompression sickness. Undersea Biomed Res 1982; 9:91-111.
6. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990; 322:1405-11.
7. Broome JR, Dick EJ. Neurologic decompression illness in swine. Aviat Space Environ Med 1996; 67:207-13.
8. Cao X, Phillis JW. Alpha-phenyl-N-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res 1994; 644:267-72.
9. Catron PW, Flynn ET Jr. Adjuvant drug therapy for decompression sickness: a review. Undersea Biomed Res 1982; 9:161-74.
10. Catron PW, Hallenbeck JM, Flynn ET, Bradley ME, Evans DE. Pathogenesis and treatment of cerebral air embolism and associated disorders. Bethesda, MD: Naval Medical Research Institute; 1984. Technical Report 84-20.
11. Choi CW, Hwang JH, Chang YS, Shin SM, Park WS, Lee M. Effects of alpha-phenyl-N-tert-butyl nitrone (PBN) on brain cell membrane function and energy metabolism during transient global cerebral hypoxia-ischemia and reoxygenation-reperfusion in newborn piglets. J Korean Med Sci 2004; 19:413-8.
12. Cogar WB. Intravenous lidocaine as adjunctive therapy in the treatment of decompression. Ann Emerg Med 1997; 29:284-6.
13. Drewry A, Gorman DF. Lidocaine as an adjunct to hyperbaric therapy in decompression illness: a case report. Undersea Biomed Res 1992; 19:187-90.
14. Dromsky DM, Weathersby PK, Fahlman A. Prophylactic high dose methylprednisolone fails to treat severe decompression sickness in swine. Aviat Space Environ Med 2003; 74:21-8.
15. Dromsky DM, Toner CB, Fahlman A, Weathersby PK. Prophylactic treatment of severe decompression sickness with methylprednisolone [Abstract]. Undersea Hyperb Med 1999; 26(Suppl.):15.
16. Dutka AJ, Francis TJ. Pathophysiology of decompression sickness. In: Bove AA, ed. Diving medicine. Philadelphia: WB Saunders; 1997:159-175.
17. Dutka AJ, Mink RB, Pearson RR, Hallenbeck JM. Effects of treatment with dexamethasone on recovery from experimental cerebral arterial gas embolism. Undersea Biomed Res 1992; 19:131-41.
18. Evans DE, Kobrine AI, LeGrys DC, Bradley ME. Protective effect of lidocaine in acute cerebral ischemia induced by air embolism. J Neurosurg 1984; 60:257-63.
19. Farooque M, Olsson Y, Hillered L. Pretreatment with alpha-phenyl-N-tert- butyl-nitrone (PBN) improves energy metabolism after spinal cord injury in rats. J Neurotrauma 1997; 14:469-76.
20. th International Symposium on Underwater and Hyperbaric Physiology; September 1986; Kobe, Japan. Bethesda, MD: Undersea and Hyperbaric Medical Society; 1987:999-1012.
21. Francis TJ, Dutka AJ. Methyl prednisolone in the treatment of acute spinal cord decompression sickness. Undersea Biomed Res 1989; 16:165-74.
22. Francis TJ, Mitchell SJ. Pathophysiology of decompression sickness. In: Brubakk AO, Newman TS, eds. Physiology and medicine of diving. New York: Sanders; 2003:530-66.
23. Gainer JL, Rudolph DB, Caraway DL. The effect of crocetin on hemorrhagic shock in rats. Circ Shock 1993; 41:1-7.
24. Giassi LJ, Gilchrist MJ, Graham MC, Gainer JL. Trans-sodium crocetinate restores blood pressure, heart rate, and plasma lactate after hemorrhagic shock. J Trauma 2001; 51:932-8.
25. Gray C, Nukada H, Jackson DM, McMorran PD, Wu A, Ma F. Neuroprotective effects of nitrone radical scavenger S-PBN on reperfusion nerve injury in rats. Brain Res 2003; 982:179-85.
26. 2 uptake and release by red cells in stopped-flow apparatus: effects of unstirred layer. Respir Physiol 1985; 59:71-91.
27. Jarden JO, Dhawan V, Moeller JR, Strother SC, Rottenberg DA. The time course of steroid action on blood-to-tumor transport of 82Rb: a positron emission tomographic study. Ann Neurol 1989; 25:239-45.
28. Lee JH, Park JW. Protective role of alpha-phenyl-N-t-butylnitrone against ionizing radiation in U937 cells and mice. Cancer Res 2003; 63:6885-93.
29. Lillo RS, Flynn ET, Homer LT. Decompression outcome following saturation dives with multiple inert gases. J Appl Physiol 1985; 59:1503-14.
30. 2 in rats. Undersea Biomed Res 1991; 18:317-31.
31. Lyle CB, Dahl EV. Protection of rapidly decompressed rats by pharmacologic and physical means. Am J Physiol 1961; 201:759-61.
32. MacGregor RR, Thorner RE, Wright DM. Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inflammatory sites. Blood 1980; 56:203-9.
33. Martin JD, Thom SR. Vascular leukocyte sequestration in decompression sickness and prophylactic hyperbaric oxygen therapy in rats. Aviat Space Environ Med 2002; 73:565-9.
34. Mitchell SJ. Lidocaine in the treatment of decompression illness: A review of the literature. Undersea Hyperb Med 2001; 28:165-74.
35. Moon RE. Treatment of decompression sickness and arterial gas embolism. In: Bove AA, ed. Diving medicine. Philadelphia: W. B. Saunders; 1997:184-204.
36. Navari RM, Hall KR, Gainer JL. Effect of plasma proteins on diffusion. In: Hershey D, ed. Blood oxygenation. New York: Plenum Press; 1970:243-61.
37. Nishina K, Mikawa K, Takao Y, Shiga M, Maekawa N, Obara H. Intravenous lidocaine attenuates acute lung injury induced by hydrochloric acid aspiration in rabbits. Anesthesiology 1998; 88:1300-9.
38. Nyquist PA, Dick EJ Jr, Buttolph TB. Detection of leukocyte activation in pigs with neurologic decompression sickness. Aviat Space Environ Med 2004; 75:211-4.
39. Patrono C. Efficacy and safety of aspirin in the long-term management of atherothrombosis. Haematologica 2001; 86(11, Suppl. 2):19-21.
40. Philp RB, Bennett PB, Anderson JC, Fields GN, McIntyre BA, Francey I, Briner W. Effects of aspirin and dipyridamole on platelet function, hematology and blood chemistry of saturation divers. Undersea Biomed Res 1979; 6:127-46.
41. Popovic P, Popovic V, Honeycutt C. Levodopa and aspirin pretreatment beneficial in experimental decompression sickness. Proc Soc Exp Biol Med 1982; 169(1):140-3.
42. Roy JW, Graham MC, Griffin AM, Gainer JL. A novel fluid resuscitation therapy for hemorrhagic shock. Shock 1998; 10:213-7.
43. Sakurai M, Mannen T, Kanazawa I, Tanabe H. Lidocaine unmasks silent demyelinative lesions in multiple sclerosis. Neurology 1992; 42:2088-92.
44. Spiegel DA, Dexter F, Warner DS, Baker MT, Todd MM. Central nervous system toxicity of local anesthetic mixtures in the rat. Anesth Analg 1992; 75:922-8.
45. Thalmann ET. Use of 100% surface oxygen in treatment of DCI. In: Moon RE, ed. Adjunctive therapy for decompression illness. Kensington: Undersea and Hyperbaric Medical Society; 2003: 129-32.
46. rd, Dhar A, Morrison DC, Longorio MA, Maxfield DM. Cellular energetics in hemorrhagic shock: restoring adenosine triphosphate to the cells. J Trauma 2003; 54(5, Suppl.)S169-76.
47. Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res 2003; 110(5-6):255-8.
48. Weissman G, ed. Mediators of inflammation. New York: Plenum Press; 1974.